FibroBiologics/$FBLG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About FibroBiologics
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
Ticker
$FBLG
Sector
Primary listing
Employees
15
Headquarters
Website
FibroBiologics Metrics
BasicAdvanced
$4.7m
-
-$6.87
1.18
-
Price and volume
Market cap
$4.7m
Beta
1.18
52-week high
$3.97
52-week low
$0.73
Average daily volume
170k
Financial strength
Current ratio
1.588
Quick ratio
0.81
Long term debt to equity
58.038
Total debt to equity
95.308
Interest coverage (TTM)
-82.63%
Profitability
EBITDA (TTM)
-16.929
Management effectiveness
Return on assets (TTM)
-123.72%
Return on equity (TTM)
-754.75%
Valuation
Price to book
1.18
Price to tangible book (TTM)
1.18
Price to free cash flow (TTM)
-0.152
Free cash flow yield (TTM)
-659.94%
Free cash flow per share (TTM)
-5.777
Growth
Earnings per share change (TTM)
53.56%
3-year earnings per share growth (CAGR)
2.19%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs